<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Prylutska S</submitter><pubmed_abstract>Dimorfolido-N-trichloroacetylphosphorylamide (HL1) and dimorfolido-N-benzoylphosphorylamide (HL2) as representatives of carbacylamidophosphates were synthesized and identified by the methods of IR, &lt;sup>1&lt;/sup>H, and &lt;sup>31&lt;/sup>P NMR spectroscopy. In vitro HL1 and HL2 at 1 mM concentration caused cell specific and time-dependent decrease of leukemic cell viability. Compounds caused the similar gradual decrease of Jurkat cells viability at 72 h (by 35%). HL1 had earlier and more profound toxic effect as compared to HL2 regardless on leukemic cell line. Viability of Molt-16 and CCRF-CEM cells under the action of HL1 was decreased at 24 h (by 32 and 45%, respectively) with no substantial further reducing up to 72 h. Toxic effect of HL2 was detected only at 72 h of incubation of Jurkat and M</pubmed_abstract><journal>Nanoscale research letters</journal><pagination>124</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5315654</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Cytotoxic Effects of Dimorfolido-N-Trichloroacetylphosphorylamide and Dimorfolido-N-Benzoylphosphorylamide in Combination with C&lt;sub>60&lt;/sub> Fullerene on Leukemic Cells and Docking Study of Their Interaction with DNA.</pubmed_title><pmcid>PMC5315654</pmcid><pubmed_authors>Hurmach V</pubmed_authors><pubmed_authors>Sliva T</pubmed_authors><pubmed_authors>Shatrava I</pubmed_authors><pubmed_authors>Prylutskyy Y</pubmed_authors><pubmed_authors>Grebinyk A</pubmed_authors><pubmed_authors>Frohme M</pubmed_authors><pubmed_authors>Slobodyanik M</pubmed_authors><pubmed_authors>Matyshevska O</pubmed_authors><pubmed_authors>Ritter U</pubmed_authors><pubmed_authors>Prylutska S</pubmed_authors><pubmed_authors>Amirkhanov V</pubmed_authors><pubmed_authors>Grynyuk I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cytotoxic Effects of Dimorfolido-N-Trichloroacetylphosphorylamide and Dimorfolido-N-Benzoylphosphorylamide in Combination with C&lt;sub>60&lt;/sub> Fullerene on Leukemic Cells and Docking Study of Their Interaction with DNA.</name><description>Dimorfolido-N-trichloroacetylphosphorylamide (HL1) and dimorfolido-N-benzoylphosphorylamide (HL2) as representatives of carbacylamidophosphates were synthesized and identified by the methods of IR, &lt;sup>1&lt;/sup>H, and &lt;sup>31&lt;/sup>P NMR spectroscopy. In vitro HL1 and HL2 at 1 mM concentration caused cell specific and time-dependent decrease of leukemic cell viability. Compounds caused the similar gradual decrease of Jurkat cells viability at 72 h (by 35%). HL1 had earlier and more profound toxic effect as compared to HL2 regardless on leukemic cell line. Viability of Molt-16 and CCRF-CEM cells under the action of HL1 was decreased at 24 h (by 32 and 45%, respectively) with no substantial further reducing up to 72 h. Toxic effect of HL2 was detected only at 72 h of incubation of Jurkat and M</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Dec</publication><modification>2025-04-18T14:38:07.81Z</modification><creation>2019-03-27T02:36:50Z</creation></dates><accession>S-EPMC5315654</accession><cross_references><pubmed>28235359</pubmed><doi>10.1186/s11671-017-1893-3</doi></cross_references></HashMap>